Epidemiology of Perioperative Anaphylaxis in France in 2017-2018: the 11th GERAP Survey

Overview

Journal Br J Anaesth

Publisher Elsevier

Specialty Anesthesiology

Date 2024 Mar 16

PMID 38493055

Authors

Charles Tacquard

Julien Serrier

Simon Viville

Anca-Mirela Chiriac

Sebastien Franchina

Aurelie Gouel-Cheron

Antoine Giraudon

Morgan Le Guen

Diane Le Quang

Jean-Marc Malinovsky

Nadine Petitpain

Pascal Demoly

Paul M Mertes

Affiliations

Soon will be listed here.

Abstract

Background: Perioperative anaphylaxis is rare but is associated with significant morbidity. This complication has been well described in France by the GERAP (Groupe d'Etude des Réactions Anaphylactiques Périopératoires), a network focused on its study. The epidemiology of perioperative anaphylaxis is evolving, influenced by environmental factors and clinical practice. The aim of this study was to update the epidemiology of perioperative anaphylaxis in France.

Methods: This multicentre retrospective study was performed in 26 allergy clinics of the GERAP network in 2017-8.

Results: There were 765 patients with perioperative anaphylaxis included. Most cases were severe, with 428 (56%) reactions graded as 3 or 4 according to the Ring and Messmer classification. Skin test results were available for 676 patients, with a culprit agent identified in 471 cases (70%). Neuromuscular blocking agents were the main cause of perioperative anaphylaxis (n=281; 60%), followed by antibiotics (n=118; 25%) and patent blue dye (n=11; 2%). Cefazolin was the main antibiotic responsible for perioperative anaphylaxis (52% of antibiotic-related reactions). Suxamethonium and rocuronium were the main neuromuscular blocking agents responsible for perioperative anaphylaxis with 7.1 (6.1-8.4) and 5.6 (4.2-7.4) reactions per 100,000 vials sold, respectively, whereas cefazolin-related cases were estimated at 0.7 (0.5-0.9) reactions per 100,000 vials sold.

Conclusions: Our results confirm that most commonly identified triggering agents remain neuromuscular blocking agents. Reactions to antibiotics, particularly cefazolin, are becoming increasingly frequent. The origin of sensitisation to cefazolin is unknown, as no cross-sensitisation has been described, and it should be the subject of further study. Perioperative anaphylaxis should be followed over the years and understood given the changing triggers.

Clinical Trial Registration: ClinicalTrials.gov (NCT04654923).

Citing Articles

Paediatric perioperative hypersensitivity: the performance of the current consensus formula and the effect of uneventful anaesthesia on serum tryptase. Reply to 2024; 9: 100254.

Vlaeminck N, van der Poorten M, Saldien V, Sabato V, Ebo D BJA Open. 2024; 12:100308.

PMID: 39350917 PMC: 11440283. DOI: 10.1016/j.bjao.2024.100308.

Management of Refractory Anaphylaxis: An Overview of Current Guidelines.

Pouessel G, Dribin T, Tacquard C, Tanno L, Cardona V, Worm M Clin Exp Allergy. 2024; 54(7):470-488.

PMID: 38866583 PMC: 11439156. DOI: 10.1111/cea.14514.

Remimazolam anaphylaxis in a patient not allergic to brotizolam: a case report and literature review.

Nakai T, Kako E, Ota H, So M, Sobue K BMC Anesthesiol. 2024; 24(1):204.

PMID: 38851690 PMC: 11161983. DOI: 10.1186/s12871-024-02591-w.

References

Ebo D, Clarke R, Mertes P, Platt P, Sabato V, Sadleir P . Molecular mechanisms and pathophysiology of perioperative hypersensitivity and anaphylaxis: a narrative review. Br J Anaesth. 2019; 123(1):e38-e49. DOI: 10.1016/j.bja.2019.01.031. View

Reddy J, Cooke P, van Schalkwyk J, Hannam J, Fitzharris P, Mitchell S . Anaphylaxis is more common with rocuronium and succinylcholine than with atracurium. Anesthesiology. 2014; 122(1):39-45. DOI: 10.1097/ALN.0000000000000512. View

Mertes P, Tacquard C . Perioperative anaphylaxis: when the allergological work-up goes negative. Curr Opin Allergy Clin Immunol. 2023; 23(4):287-293. DOI: 10.1097/ACI.0000000000000912. View

Chiriac A, Tacquard C, Fadhel N, Pellerin C, Malinovsky J, Mertes P . Safety of subsequent general anaesthesia in patients allergic to neuromuscular blocking agents: value of allergy skin testing. Br J Anaesth. 2018; 120(6):1437-1440. DOI: 10.1016/j.bja.2018.03.004. View

Garvey L, Dewachter P, Hepner D, Mertes P, Voltolini S, Clarke R . Management of suspected immediate perioperative allergic reactions: an international overview and consensus recommendations. Br J Anaesth. 2019; 123(1):e50-e64. DOI: 10.1016/j.bja.2019.04.044. View

Mertes P, Malinovsky J, Jouffroy L, Aberer W, Terreehorst I, Brockow K . Reducing the risk of anaphylaxis during anesthesia: 2011 updated guidelines for clinical practice. J Investig Allergol Clin Immunol. 2011; 21(6):442-53. View

Sugiyama Y, Takazawa T, Watanabe N, Bito K, Fujiyoshi T, Hamaguchi S . The Japanese Epidemiologic Study for Perioperative Anaphylaxis, a prospective nationwide study: clinical signs, severity, and therapeutic agents. Br J Anaesth. 2023; 131(1):170-177. DOI: 10.1016/j.bja.2023.02.023. View

Bogas G, Dona I, Dionicio J, Fernandez T, Mayorga C, Boteanu C . Diagnostic Approach of Hypersensitivity Reactions to Cefazolin in a Large Prospective Cohort. J Allergy Clin Immunol Pract. 2021; 9(12):4421-4430.e4. DOI: 10.1016/j.jaip.2021.08.017. View

Reitter M, Petitpain N, Latarche C, Cottin J, Massy N, Demoly P . Fatal anaphylaxis with neuromuscular blocking agents: a risk factor and management analysis. Allergy. 2014; 69(7):954-9. DOI: 10.1111/all.12426. View

10.

Wade R, Burr N, McCauley G, Bourke G, Efthimiou O . The Comparative Efficacy of Chlorhexidine Gluconate and Povidone-iodine Antiseptics for the Prevention of Infection in Clean Surgery: A Systematic Review and Network Meta-analysis. Ann Surg. 2020; 274(6):e481-e488. DOI: 10.1097/SLA.0000000000004076. View

11.

Sadleir P, Clarke R, Goddard C, Day C, Weightman W, Middleditch A . Relationship of perioperative anaphylaxis to neuromuscular blocking agents, obesity, and pholcodine consumption: a case-control study. Br J Anaesth. 2021; 126(5):940-948. DOI: 10.1016/j.bja.2020.12.018. View

12.

Sadleir P, Clarke R, Bozic B, Platt P . Consequences of proceeding with surgery after resuscitation from intra-operative anaphylaxis. Anaesthesia. 2017; 73(1):32-39. DOI: 10.1111/anae.14106. View

13.

Tacquard C, Collange O, Gomis P, Malinovsky J, Petitpain N, Demoly P . Anaesthetic hypersensitivity reactions in France between 2011 and 2012: the 10th GERAP epidemiologic survey. Acta Anaesthesiol Scand. 2017; 61(3):290-299. DOI: 10.1111/aas.12855. View

14.

Laxenaire M, Mertes P . Anaphylaxis during anaesthesia. Results of a two-year survey in France. Br J Anaesth. 2002; 87(4):549-58. DOI: 10.1093/bja/87.4.549. View

15.

Mertes P, Alla F, Trechot P, Auroy Y, Jougla E . Anaphylaxis during anesthesia in France: an 8-year national survey. J Allergy Clin Immunol. 2011; 128(2):366-73. DOI: 10.1016/j.jaci.2011.03.003. View

16.

Baretto R, Beck S, Heslegrave J, Melchior C, Mohamed O, Ekbote A . Validation of international consensus equation for acute serum total tryptase in mast cell activation: A perioperative perspective. Allergy. 2017; 72(12):2031-2034. DOI: 10.1111/all.13226. View

17.

Clergue F, Auroy Y, Pequignot F, Jougla E, Lienhart A, Laxenaire M . French survey of anesthesia in 1996. Anesthesiology. 1999; 91(5):1509-20. DOI: 10.1097/00000542-199911000-00045. View

18.

Ebo D, Faber M, Elst J, Van Gasse A, Bridts C, Mertens C . In Vitro Diagnosis of Immediate Drug Hypersensitivity During Anesthesia: A Review of the Literature. J Allergy Clin Immunol Pract. 2018; 6(4):1176-1184. DOI: 10.1016/j.jaip.2018.01.004. View

19.

Mertes P, Petitpain N, Tacquard C, Delpuech M, Baumann C, Malinovsky J . Pholcodine exposure increases the risk of perioperative anaphylaxis to neuromuscular blocking agents: the ALPHO case-control study. Br J Anaesth. 2023; 131(1):150-158. DOI: 10.1016/j.bja.2023.02.026. View

20.

Mertes P, Ebo D, Garcez T, Rose M, Sabato V, Takazawa T . Comparative epidemiology of suspected perioperative hypersensitivity reactions. Br J Anaesth. 2019; 123(1):e16-e28. DOI: 10.1016/j.bja.2019.01.027. View